FA
NUVA

FDx Advisors’s NuVasive, Inc. NUVA Stock Holding History

FDx Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,795
Closed -$252K – 918
2021
Q4 		$252K Buy
4,795
+960
+25% +$52.2K 0.01% 762
2021
Q3 		$230K Buy
3,835
+645
+20% +$39.8K 0.01% 758
2021
Q2 		$216K Buy
+3,190
New +$218K 0.01% 765

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

FDx Advisors's NUVA Position: Q1 2022 in Review

FDx Advisors sold out of NuVasive, Inc. (NUVA) in Q1 2022, closing a stake of 4,795 shares — an estimated $252K sold.

FDx Advisors first reported a position in NUVA in Q2 2021 and held it in 3 quarters. The position peaked at $252K in Q4 2021. 245 funds tracked by Wall St. Rank hold NUVA as of Q1 2022.

  • FDx Advisors reported no remaining NuVasive, Inc. position as of Q1 2022 after selling out during the quarter.
  • FDx Advisors sold 4,795 NuVasive, Inc. shares in Q1 2022, an estimated $252K.
  • FDx Advisors first reported a position in NuVasive, Inc. in Q2 2021 and held it in 3 quarters.
  • FDx Advisors's NuVasive, Inc. position peaked at $252K in Q4 2021.
  • 245 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2022.

Based on FDx Advisors's 13F filing for Q1 2022, filed 3 May 2022.